跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free - TGA Drug Approval Details
Approvals
/
TGA
/
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free
Approved
STANDARD
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jul 12, 2025
Approval ID
caa0a4901f1324c3
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
caa0a4901f1324c3
Product Name
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free
Artg Id
452625
Artg Name
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2025-07-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jul 12, 2025
Approval ID
caa0a4901f1324c3
Type
Standard
Back to TGA Approvals